Rowland Thomas Andrew 4

What Happened

• Rowland T. Andrew, SVP & Head — Established Brands at ANI Pharmaceuticals, had 1,762 shares of ANI common stock disposed (withheld) to cover tax liabilities tied to the vesting of performance awards. The shares were valued at $76.25 each for a total of $134,353.
• The withholding is reported under transaction code F (tax withholding/cashless settlement) and relates to the vesting of 5,788 performance stock units previously granted.

Key Details

• Transaction date: 2026-02-11; filing date: 2026-02-13 (timely within typical reporting window).
• Price per share: $76.25; total value of shares withheld: $134,353.
• Filing footnote F1: Shares were withheld for tax purposes in connection with vesting of 5,788 performance stock units (grant previously reported).
• Filing footnote F2: Notes inclusion of 128 shares acquired under the company’s Employee Stock Purchase Plan in exempt transactions.
• Shares owned after the transaction: not specified in the provided summary of the filing.

Context

• This was a tax-withholding transaction (not an open-market sale). Companies often withhold or sell a portion of vested award shares to cover withholding obligations; such transactions are routine and do not necessarily indicate the insider’s view of the stock.
• For retail investors, outright purchases by insiders are generally more informative than withholding or routine disposals.